| Field | Row 1 | Row 2 | Row 3 |
|---|---|---|---|
| adsh | 0001477932-25-004112 | 0001477932-25-004043 | 0001477932-25-002561 |
| cik | 1284454 | 1284454 | 1284454 |
| name | NONGFU SHOP DIGITAL NEW RETAIL CO., LTD | NONGFU SHOP DIGITAL NEW RETAIL CO., LTD | YONG BAI CHAO NEW RETAIL CORP |
| sic | 3714 | 3714 | 3714 |
| countryba | CN | ||
| stprba | |||
| cityba | SHANGHAI | SHANGHAI | SHANGHAI |
| zipba | 00000 | 00000 | 00000 |
| bas1 | 3209, SOUTH BUILDING, BUILDING 3, NO. 39 | 3209, SOUTH BUILDING, BUILDING 3, NO. 39 | 3209, SOUTH BUILDING, BUILDING 3, NO. 39 |
| bas2 | BOASHAN DISTRICT | BOASHAN DISTRICT | BOASHAN DISTRICT |
| baph | 18621601569 | 18621601569 | 18621601569 |
| countryma | CN | ||
| stprma | |||
| cityma | SHANGHAI | SHANGHAI | SHANGHAI |
| zipma | 00000 | 00000 | 00000 |
| mas1 | 3209, SOUTH BUILDING, BUILDING 3, NO. 39 | 3209, SOUTH BUILDING, BUILDING 3, NO. 39 | 3209, SOUTH BUILDING, BUILDING 3, NO. 39 |
| mas2 | BOASHAN DISTRICT | BOASHAN DISTRICT | BOASHAN DISTRICT |
| countryinc | |||
| stprinc | |||
| ein | 203626387 | 203626387 | 203626387 |
| former | YONG BAI CHAO NEW RETAIL CORP | YONG BAI CHAO NEW RETAIL CORP | ENVIRONMENTAL CONTROL CORP. |
| changed | 20211110 | 20211110 | 20060321 |
| afs | 4-NON | 4-NON | 4-NON |
| wksi | 0 | 0 | 0 |
| fye | 1231 | 1231 | 1231 |
| form | 10-K/A | 10-Q | 10-K |
| period | 20241231 | 20250331 | 20241231 |
| fy | 2024 | 2025 | 2024 |
| fp | FY | Q1 | FY |
| filed | 20250522 | 20250520 | 20250410 |
| accepted | 2025-05-22 16:35:00.0 | 2025-05-20 17:31:00.0 | 2025-04-09 19:25:00.0 |
| prevrpt | 0 | 0 | 0 |
| detail | 1 | 1 | 1 |
| instance | ybcn_10ka_htm.xml | ybcn_10q_htm.xml | ybcn_10k_htm.xml |
| nciks | 1 | 1 | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001477932-25-002561 | 20231231 | Common Stock Shares Outstanding | 189120068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Due To Related Party Current | 99337.0000 | USD | 0 | 0001477932-25-002561 | |||
| 0001477932-25-002561 | 20241231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-002561 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Revenues | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Stockholders Equity | 195496.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-002561 | 20231231 | Weighted Average Number Of Diluted Shares Outstanding | 189120068.0000 | shares | 4 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Common Stock To Be Issued | 2282.0000 | USD | 0 | 0001477932-25-004043 | |||
| 0001477932-25-004043 | 20240331 | Increase Decrease In Due To Related Parties | 750.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Interest Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Interest Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Net Income Loss | -10466.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Shares Issued | 375000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004043 | 20240331 | Stockholders Equity | 2282.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-004112 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Common Stock Shares Issued | 189495068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Common Stock Value | 195496.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Interest Paid Net | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Liabilities Current | 106659.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Net Cash Provided By Used In Operating Activities | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Net Income Loss | -39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-004112 | 20241231 | Operating Expenses | 39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Operating Income Loss | -62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Retained Earnings Accumulated Deficit | -3675708.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Shares Issued | 189120068.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004112 | 20221231 | Stockholders Equity | 3371271.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-004112 | 20231231 | Stockholders Equity | -3675708.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-004112 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004112 | 20221231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-002561 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Profit Loss | -62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Assets Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20221231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Common Stock Shares Authorized | 190000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Common Stock To Be Issued | 2282.0000 | USD | 0 | 0001477932-25-002561 | |||
| 0001477932-25-002561 | 20231231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Increase Decrease In Accounts Payable And Accrued Liabilities | 5354.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Preferred Stock No Par Value | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20221231 | Shares Issued | 375000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-002561 | 20241231 | Shares Issued | 375000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-002561 | 20231231 | Additional Paid In Capital | 3371271.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Additional Paid In Capital | 3371271.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Assets Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Common Stock Shares Authorized | 190000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Common Stock To Be Issued | 2282.0000 | USD | 0 | 0001477932-25-002561 | |||
| 0001477932-25-002561 | 20241231 | Liabilities Current | 146453.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Net Income Loss | -62017.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-002561 | 20241231 | Preferred Stock No Par Value | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Retained Earnings Accumulated Deficit | -3675708.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Retained Earnings Accumulated Deficit | -3715502.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20221231 | Stockholders Equity | -44642.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Stockholders Equity | -106659.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Stockholders Equity | 2282.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-002561 | 20241231 | Stockholders Equity | 2282.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-002561 | 20241231 | Treasury Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -17833.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 17083.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 5581.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Net Income Loss | -17833.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Net Income Loss | -17833.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-004043 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Professional Fees | 17833.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Profit Loss | -17833.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Revenues | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Shares Issued | 189120068.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004043 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004112 | 20231231 | Liabilities And Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Accounts Payable And Accrued Liabilities Current | 7322.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Accounts Payable And Accrued Liabilities Current | 11490.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Common Stock Shares Outstanding | 189120068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Income Taxes Paid Net | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Income Taxes Paid Net | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Operating Expenses | 62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Operating Income Loss | -39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Assets | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Common Stock Shares Issued | 189495068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Common Stock Shares Outstanding | 189120068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Earnings Per Share Diluted | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Increase Decrease In Due To Related Parties | 56663.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-002561 | 20231231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Professional Fees | 62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Profit Loss | -39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Revenues | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20221231 | Shares Issued | 189120068.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-002561 | 20221231 | Stockholders Equity | 2282.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-002561 | 20221231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-002561 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004043 | 20250331 | Accounts Payable And Accrued Liabilities Current | 17071.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Assets | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Assets Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Common Stock To Be Issued | 2282.0000 | USD | 0 | 0001477932-25-004043 | |||
| 0001477932-25-004043 | 20240331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Increase Decrease In Due To Related Parties | 4885.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004043 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-004043 | 20250331 | Professional Fees | 10466.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Retained Earnings Accumulated Deficit | -3715502.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20231231 | Shares Issued | 375000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004043 | 20250331 | Shares Issued | 375000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004043 | 20231231 | Stockholders Equity | 195496.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004043 | 20241231 | Stockholders Equity | 3371271.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-004043 | 20250331 | Stockholders Equity | 195496.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004043 | 20241231 | Treasury Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 189120068.0000 | shares | 1 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Assets Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Due To Related Party Current | 99337.0000 | USD | 0 | 0001477932-25-004112 | |||
| 0001477932-25-004112 | 20241231 | Increase Decrease In Due To Related Parties | 35626.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Interest Paid Net | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Net Cash Provided By Used In Operating Activities | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-004112 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Professional Fees | 39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20221231 | Shares Issued | 375000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004112 | 20221231 | Stockholders Equity | 195496.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004112 | 20221231 | Stockholders Equity | -3613691.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-004112 | 20231231 | Stockholders Equity | 195496.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004112 | 20241231 | Stockholders Equity | 3371271.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-004112 | 20231231 | Weighted Average Number Of Diluted Shares Outstanding | 189120068.0000 | shares | 4 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Additional Paid In Capital | 3371271.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Assets Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Common Stock Shares Authorized | 190000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Common Stock Shares Outstanding | 189120068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Common Stock Value | 195496.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Due To Related Party Current | 134963.0000 | USD | 0 | 0001477932-25-004043 | Related Party Transactions By Related Party= Ceo Fei Wang; | ||
| 0001477932-25-004043 | 20250331 | Due To Related Party Current | 139848.0000 | USD | 0 | 0001477932-25-004043 | Related Party Transactions By Related Party= Ceo Fei Wang; | ||
| 0001477932-25-004043 | 20240331 | Income Taxes Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Interest Expense | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004043 | 20250331 | Operating Expenses | 10466.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Operating Income Loss | -17833.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Other Noncash Income Expense | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20231231 | Shares Issued | 189120068.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004043 | 20241231 | Shares Issued | 189120068.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004043 | 20231231 | Stockholders Equity | 2282.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-004043 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004043 | 20240331 | Stockholders Equity | -124492.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Stockholders Equity | 2282.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-004043 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004043 | 20250331 | Stockholders Equity | -3725968.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-004043 | 20250331 | Treasury Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Common Stock Shares Outstanding | 189120068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Due To Related Party Current | 134963.0000 | USD | 0 | 0001477932-25-004112 | |||
| 0001477932-25-004112 | 20231231 | Income Tax Expense Benefit | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Income Tax Expense Benefit | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-004112 | 20221231 | Shares Issued | 189120068.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-002561 | 20231231 | Accounts Payable And Accrued Liabilities Current | 7322.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Assets | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Due To Related Party Current | 134963.0000 | USD | 0 | 0001477932-25-002561 | |||
| 0001477932-25-002561 | 20231231 | Earnings Per Share Diluted | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Increase Decrease In Due To Related Parties | 35626.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Net Income Loss | -62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-002561 | 20241231 | Net Income Loss | -39794.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-002561 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Shares Issued | 189120068.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-002561 | 20221231 | Stockholders Equity | 195496.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-002561 | 20241231 | Stockholders Equity | -146453.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Stockholders Equity | 3371271.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-002561 | 20231231 | Treasury Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Stockholders Equity | -3715502.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-002561 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Income Taxes Paid Net | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Increase Decrease In Accounts Payable And Accrued Liabilities | 4168.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Liabilities Current | 106659.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-002561 | 20231231 | Operating Expenses | 62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Operating Income Loss | -62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Shares Issued | 189120068.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-002561 | 20231231 | Shares Issued | 375000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-002561 | 20241231 | Stockholders Equity | 195496.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-002561 | 20241231 | Weighted Average Number Of Diluted Shares Outstanding | 189120068.0000 | shares | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Common Stock Shares Issued | 189495068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Common Stock Value | 195496.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Common Stock Value | 195496.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Income Taxes Paid Net | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Income Tax Expense Benefit | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Income Tax Expense Benefit | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Interest Paid Net | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Interest Paid Net | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Net Cash Provided By Used In Operating Activities | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Net Cash Provided By Used In Operating Activities | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-002561 | 20241231 | Net Income Loss | -39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-002561 | 20241231 | Operating Expenses | 39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Professional Fees | 39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20221231 | Stockholders Equity | 3371271.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-002561 | 20221231 | Stockholders Equity | -3613691.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-002561 | 20231231 | Stockholders Equity | -3675708.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-002561 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004043 | 20241231 | Accounts Payable And Accrued Liabilities Current | 11490.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Common Stock Shares Authorized | 190000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Common Stock Shares Outstanding | 189120068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Income Taxes Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Liabilities And Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004043 | 20240331 | Other Noncash Income Expense | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Retained Earnings Accumulated Deficit | -3725968.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Shares Issued | 189120068.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004043 | 20241231 | Stockholders Equity | -146453.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004112 | 20231231 | Common Stock Shares Authorized | 190000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Common Stock Shares Authorized | 190000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Increase Decrease In Due To Related Parties | 56663.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004112 | 20241231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004112 | 20231231 | Preferred Stock No Par Value | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Preferred Stock No Par Value | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Profit Loss | -62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20221231 | Stockholders Equity | -44642.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Stockholders Equity | 2282.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-002561 | 20241231 | Accounts Payable And Accrued Liabilities Current | 11490.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Cash | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Cash | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Liabilities And Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20241231 | Liabilities And Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-002561 | 20241231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-002561 | 20241231 | Operating Income Loss | -39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-002561 | 20231231 | Stockholders Equity | 3371271.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-002561 | 20241231 | Stockholders Equity | -3715502.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-004043 | 20250331 | Additional Paid In Capital | 3371271.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Common Stock Shares Issued | 189495068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Common Stock Value | 195496.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Net Income Loss | -10466.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-004043 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Revenues | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20231231 | Stockholders Equity | -3675708.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-004043 | 20250331 | Stockholders Equity | -156919.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Additional Paid In Capital | 3371271.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Additional Paid In Capital | 3371271.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Assets | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Assets | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20221231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Common Stock To Be Issued | 2282.0000 | USD | 0 | 0001477932-25-004112 | |||
| 0001477932-25-004112 | 20241231 | Common Stock To Be Issued | 2282.0000 | USD | 0 | 0001477932-25-004112 | |||
| 0001477932-25-004112 | 20231231 | Earnings Per Share Diluted | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Earnings Per Share Diluted | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Increase Decrease In Accounts Payable And Accrued Liabilities | 5354.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Net Income Loss | -62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Net Income Loss | -39794.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-004112 | 20231231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Professional Fees | 62017.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Retained Earnings Accumulated Deficit | -3715502.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Shares Issued | 375000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004112 | 20241231 | Shares Issued | 375000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004112 | 20221231 | Stockholders Equity | 2282.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-004112 | 20231231 | Treasury Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Treasury Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20231231 | Stockholders Equity | -106659.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Assets | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -10466.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Liabilities Current | 146453.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Net Cash Provided By Used In Operating Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Net Cash Provided By Used In Operating Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-004043 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-004043 | 20240331 | Operating Expenses | 17833.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Preferred Stock No Par Value | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Profit Loss | -10466.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20231231 | Stockholders Equity | 3371271.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-004043 | 20240331 | Stockholders Equity | 3371271.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-004043 | 20241231 | Stockholders Equity | 195496.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004043 | 20250331 | Stockholders Equity | 3371271.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-004043 | 20250331 | Stockholders Equity | 2282.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-004112 | 20241231 | Assets Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Cash | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Increase Decrease In Accounts Payable And Accrued Liabilities | 4168.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Liabilities And Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Liabilities Current | 146453.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004112 | 20241231 | Profit Loss | -39794.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Revenues | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Stockholders Equity | -106659.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Stockholders Equity | 3371271.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-004112 | 20241231 | Stockholders Equity | 195496.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004112 | 20241231 | Weighted Average Number Of Diluted Shares Outstanding | 189120068.0000 | shares | 4 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Common Stock Shares Issued | 189495068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20091231 | Common Stock To Be Issued | 2282.0000 | USD | 0 | 0001477932-25-004043 | |||
| 0001477932-25-004043 | 20241231 | Due To Related Party Current | 134963.0000 | USD | 0 | 0001477932-25-004043 | |||
| 0001477932-25-004043 | 20250331 | Due To Related Party Current | 139848.0000 | USD | 0 | 0001477932-25-004043 | |||
| 0001477932-25-004043 | 20250331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Interest Expense | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Liabilities And Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Liabilities Current | 156919.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001477932-25-004043 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004043 | 20250331 | Operating Income Loss | -10466.0000 | USD | 1 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Preferred Stock No Par Value | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004043 | 20240331 | Shares Issued | 375000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001477932-25-004043 | 20240331 | Stockholders Equity | 195496.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004043 | 20240331 | Stockholders Equity | -3693541.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-004043 | 20241231 | Stockholders Equity | -3715502.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-004043 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 189120068.0000 | shares | 1 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Cash | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Common Stock Shares Issued | 189495068.0000 | shares | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Common Stock Value | 195496.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Net Income Loss | -62017.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001477932-25-004112 | 20241231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004112 | 20241231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-004112 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20231231 | Revenues | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Shares Issued | 189120068.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001477932-25-004112 | 20241231 | Stockholders Equity | -146453.0000 | USD | 0 | us-gaap/2024 | |||
| 0001477932-25-004112 | 20241231 | Stockholders Equity | 2282.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001477932-25-004112 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Professional Fees | us-gaap/2024 | 0 | 0 | monetary | D | D | Professional Fees | A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock To Be Issued | 0001477932-25-002561 | 1 | 0 | monetary | I | C | Common stock to be issued | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Due To Related Party Current | 0001477932-25-004043 | 1 | 0 | monetary | I | C | Due to related party | |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Increase Decrease In Due To Related Parties | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Due to Related Parties | The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Treasury Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Treasury Stock, Value | The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Common Stock To Be Issued | 0001477932-25-004112 | 1 | 0 | monetary | I | C | Common stock to be issued | |
| Interest Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Operating and Nonoperating | Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. |
| Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Shares, Issued | Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. | |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Common Stock To Be Issued | 0001477932-25-004043 | 1 | 0 | monetary | I | C | Common stock to be issued | |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Other Noncash Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Noncash Income (Expense) | Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Due To Related Party Current | 0001477932-25-004112 | 1 | 0 | monetary | I | C | Due to related party | |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Preferred Stock No Par Value | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, No Par Value | Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Due To Related Party Current | 0001477932-25-002561 | 1 | 0 | monetary | I | C | Due to related party |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001477932-25-002561 | 2 | 1 | BS | 0 | H | Cash | us-gaap/2024 | Cash | 0 |
| 0001477932-25-002561 | 2 | 2 | BS | 0 | H | Assets Current | us-gaap/2024 | TOTAL CURRENT ASSETS | 0 |
| 0001477932-25-002561 | 2 | 3 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0001477932-25-002561 | 2 | 5 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
| 0001477932-25-002561 | 2 | 6 | BS | 0 | H | Due To Related Party Current | 0001477932-25-002561 | Due to related party | 0 |
| 0001477932-25-002561 | 2 | 7 | BS | 0 | H | Liabilities Current | us-gaap/2024 | TOTAL CURRENT LIABILITIES | 0 |
| 0001477932-25-002561 | 2 | 10 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock ($0.001 par value; 10,000,000 shares authorized; 0 share issued and outstanding at December 31, 2024 and 2023) | 0 |
| 0001477932-25-002561 | 2 | 11 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock ($0.001 par value; 190,000,000 shares authorized; 189,495,068 shares issued and 189,120,068 shares outstanding at December 31, 2024 and 2023) | 0 |
| 0001477932-25-002561 | 2 | 12 | BS | 0 | H | Common Stock To Be Issued | 0001477932-25-002561 | Common stock to be issued | 0 |
| 0001477932-25-002561 | 2 | 13 | BS | 0 | H | Treasury Stock Value | us-gaap/2024 | Treasury Stock | 0 |
| 0001477932-25-002561 | 2 | 14 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001477932-25-002561 | 2 | 15 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001477932-25-002561 | 2 | 16 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | TOTAL STOCKHOLDERS' DEFICIT | 0 |
| 0001477932-25-002561 | 2 | 17 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | 0 |
| 0001477932-25-002561 | 3 | 1 | BS | 1 | H | Preferred Stock No Par Value | us-gaap/2024 | Preferred Stock, Shares Par Value | 0 |
| 0001477932-25-002561 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred Stock Shares Authorized | 0 |
| 0001477932-25-002561 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred Stock Shares Issued | 0 |
| 0001477932-25-002561 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred Stock Shares Outstanding | 0 |
| 0001477932-25-002561 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common Stock, Shares Par Value | 0 |
| 0001477932-25-002561 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common Stock Shares Authorized | 0 |
| 0001477932-25-002561 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common Stock Shares Issued | 0 |
| 0001477932-25-002561 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common Stock Shares Outstanding | 0 |
| 0001477932-25-002561 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2024 | Revenue | 0 |
| 0001477932-25-002561 | 4 | 3 | IS | 0 | H | Professional Fees | us-gaap/2024 | Professional fees | 0 |
| 0001477932-25-002561 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total Operating Expenses | 0 |
| 0001477932-25-002561 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from Operations | 0 |
| 0001477932-25-002561 | 4 | 6 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss Before Income Taxes | 0 |
| 0001477932-25-002561 | 4 | 7 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income Taxes | 0 |
| 0001477932-25-002561 | 4 | 8 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net Loss | 0 |
| 0001477932-25-002561 | 4 | 10 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Basic and diluted | 0 |
| 0001477932-25-002561 | 4 | 11 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Basic and diluted | 0 |
| 0001477932-25-002561 | 5 | 10 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001477932-25-002561 | 5 | 11 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001477932-25-002561 | 5 | 12 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001477932-25-002561 | 5 | 13 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001477932-25-002561 | 5 | 14 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001477932-25-002561 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001477932-25-002561 | 6 | 4 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
| 0001477932-25-002561 | 6 | 5 | CF | 0 | H | Increase Decrease In Due To Related Parties | us-gaap/2024 | Due to related party | 0 |
| 0001477932-25-002561 | 6 | 6 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | NET CASH USED IN OPERATING ACTIVITIES | 0 |
| 0001477932-25-002561 | 6 | 7 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | NET INCREASE IN CASH | 0 |
| 0001477932-25-002561 | 6 | 8 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, beginning of period | 0 |
| 0001477932-25-002561 | 6 | 9 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, end of period | 0 |
| 0001477932-25-002561 | 6 | 11 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001477932-25-002561 | 6 | 12 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Cash paid for income tax | 0 |
| 0001477932-25-004043 | 2 | 1 | BS | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash | 0 |
| 0001477932-25-004043 | 2 | 2 | BS | 0 | H | Assets Current | us-gaap/2024 | TOTAL CURRENT ASSETS | 0 |
| 0001477932-25-004043 | 2 | 3 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0001477932-25-004043 | 2 | 6 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
| 0001477932-25-004043 | 2 | 7 | BS | 0 | H | Due To Related Party Current | 0001477932-25-004043 | Due to related party | 0 |
| 0001477932-25-004043 | 2 | 8 | BS | 0 | H | Liabilities Current | us-gaap/2024 | TOTAL CURRENT LIABILITIES | 0 |
| 0001477932-25-004043 | 2 | 11 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock ($0.001 par value; 10,000,000 shares authorized; 0 share issued and outstanding at March 31, 2025 and December 31, 2024) | 0 |
| 0001477932-25-004043 | 2 | 12 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock ($0.001 par value; 190,000,000 shares authorized; 189,495,068 shares issued and 189,120,068 shares outstanding at March 31, 2025 and December 31, 2024) | 0 |
| 0001477932-25-004043 | 2 | 13 | BS | 0 | H | Common Stock To Be Issued | 0001477932-25-004043 | Common stock to be issued | 0 |
| 0001477932-25-004043 | 2 | 14 | BS | 0 | H | Treasury Stock Value | us-gaap/2024 | Treasury Stock | 0 |
| 0001477932-25-004043 | 2 | 15 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001477932-25-004043 | 2 | 16 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001477932-25-004043 | 2 | 17 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | TOTAL STOCKHOLDERS' DEFICIT | 0 |
| 0001477932-25-004043 | 2 | 18 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | 0 |
| 0001477932-25-004043 | 3 | 1 | BS | 1 | H | Preferred Stock No Par Value | us-gaap/2024 | Preferred Stock, Shares Par Value | 0 |
| 0001477932-25-004043 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred Stock Shares Authorized | 0 |
| 0001477932-25-004043 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred Stock Shares Issued | 0 |
| 0001477932-25-004043 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred Stock Shares Outstanding | 0 |
| 0001477932-25-004043 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common Stock, Shares Par Value | 0 |
| 0001477932-25-004043 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common Stock Shares Authorized | 0 |
| 0001477932-25-004043 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common Stock Shares Issued | 0 |
| 0001477932-25-004043 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common Stock Shares Outstanding | 0 |
| 0001477932-25-004043 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2024 | Revenue | 0 |
| 0001477932-25-004043 | 4 | 3 | IS | 0 | H | Professional Fees | us-gaap/2024 | Professional fees | 0 |
| 0001477932-25-004043 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total Operating Expenses | 0 |
| 0001477932-25-004043 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from Operations | 0 |
| 0001477932-25-004043 | 4 | 7 | IS | 0 | H | Interest Expense | us-gaap/2024 | Interest expense | 0 |
| 0001477932-25-004043 | 4 | 8 | IS | 0 | H | Other Noncash Income Expense | us-gaap/2024 | Total Other Income (Expense) | 0 |
| 0001477932-25-004043 | 4 | 9 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss Before Income Taxes | 0 |
| 0001477932-25-004043 | 4 | 10 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income Taxes | 0 |
| 0001477932-25-004043 | 4 | 11 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net Loss | 0 |
| 0001477932-25-004043 | 4 | 13 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Basic and diluted | 0 |
| 0001477932-25-004043 | 4 | 14 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Basic and diluted | 0 |
| 0001477932-25-004043 | 5 | 10 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001477932-25-004043 | 5 | 11 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001477932-25-004043 | 5 | 12 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001477932-25-004043 | 5 | 13 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001477932-25-004043 | 5 | 14 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001477932-25-004043 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001477932-25-004043 | 6 | 4 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
| 0001477932-25-004043 | 6 | 5 | CF | 0 | H | Increase Decrease In Due To Related Parties | us-gaap/2024 | Due to related party | 0 |
| 0001477932-25-004043 | 6 | 6 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | NET CASH USED IN OPERATING ACTIVITIES | 0 |
| 0001477932-25-004043 | 6 | 7 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | NET INCREASE IN CASH | 0 |
| 0001477932-25-004043 | 6 | 8 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, beginning of period | 0 |
| 0001477932-25-004043 | 6 | 9 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, end of period | 0 |
| 0001477932-25-004043 | 6 | 11 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001477932-25-004043 | 6 | 12 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Cash paid for income tax | 0 |
| 0001477932-25-004112 | 2 | 1 | BS | 0 | H | Cash | us-gaap/2024 | Cash | 0 |
| 0001477932-25-004112 | 2 | 2 | BS | 0 | H | Assets Current | us-gaap/2024 | TOTAL CURRENT ASSETS | 0 |
| 0001477932-25-004112 | 2 | 3 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0001477932-25-004112 | 2 | 5 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
| 0001477932-25-004112 | 2 | 6 | BS | 0 | H | Due To Related Party Current | 0001477932-25-004112 | Due to related party | 0 |
| 0001477932-25-004112 | 2 | 7 | BS | 0 | H | Liabilities Current | us-gaap/2024 | TOTAL CURRENT LIABILITIES | 0 |
| 0001477932-25-004112 | 2 | 10 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock ($0.001 par value; 10,000,000 shares authorized; 0 share issued and outstanding at December 31, 2024 and 2023) | 0 |
| 0001477932-25-004112 | 2 | 11 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock ($0.001 par value; 190,000,000 shares authorized; 189,495,068 shares issued and 189,120,068 shares outstanding at December 31, 2024 and 2023) | 0 |
| 0001477932-25-004112 | 2 | 12 | BS | 0 | H | Common Stock To Be Issued | 0001477932-25-004112 | Common stock to be issued | 0 |
| 0001477932-25-004112 | 2 | 13 | BS | 0 | H | Treasury Stock Value | us-gaap/2024 | Treasury Stock | 0 |
| 0001477932-25-004112 | 2 | 14 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001477932-25-004112 | 2 | 15 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001477932-25-004112 | 2 | 16 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | TOTAL STOCKHOLDERS' DEFICIT | 0 |
| 0001477932-25-004112 | 2 | 17 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | 0 |
| 0001477932-25-004112 | 3 | 1 | BS | 1 | H | Preferred Stock No Par Value | us-gaap/2024 | Preferred Stock, Shares Par Value | 0 |
| 0001477932-25-004112 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred Stock Shares Authorized | 0 |
| 0001477932-25-004112 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred Stock Shares Issued | 0 |
| 0001477932-25-004112 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred Stock Shares Outstanding | 0 |
| 0001477932-25-004112 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common Stock, Shares Par Value | 0 |
| 0001477932-25-004112 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common Stock Shares Authorized | 0 |
| 0001477932-25-004112 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common Stock Shares Issued | 0 |
| 0001477932-25-004112 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common Stock Shares Outstanding | 0 |
| 0001477932-25-004112 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2024 | Revenue | 0 |
| 0001477932-25-004112 | 4 | 3 | IS | 0 | H | Professional Fees | us-gaap/2024 | Professional fees | 0 |
| 0001477932-25-004112 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total Operating Expenses | 0 |
| 0001477932-25-004112 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from Operations | 0 |
| 0001477932-25-004112 | 4 | 6 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss Before Income Taxes | 0 |
| 0001477932-25-004112 | 4 | 7 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income Taxes | 0 |
| 0001477932-25-004112 | 4 | 8 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net Loss | 0 |
| 0001477932-25-004112 | 4 | 10 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Basic and diluted | 0 |
| 0001477932-25-004112 | 4 | 11 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Basic and diluted | 0 |
| 0001477932-25-004112 | 5 | 10 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001477932-25-004112 | 5 | 11 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001477932-25-004112 | 5 | 12 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001477932-25-004112 | 5 | 13 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001477932-25-004112 | 5 | 14 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001477932-25-004112 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001477932-25-004112 | 6 | 4 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
| 0001477932-25-004112 | 6 | 5 | CF | 0 | H | Increase Decrease In Due To Related Parties | us-gaap/2024 | Due to related party | 0 |
| 0001477932-25-004112 | 6 | 6 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | NET CASH USED IN OPERATING ACTIVITIES | 0 |
| 0001477932-25-004112 | 6 | 7 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | NET INCREASE IN CASH | 0 |
| 0001477932-25-004112 | 6 | 8 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, beginning of period | 0 |
| 0001477932-25-004112 | 6 | 9 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, end of period | 0 |
| 0001477932-25-004112 | 6 | 11 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001477932-25-004112 | 6 | 12 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Cash paid for income tax | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |